Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN44202629
ISRCTN44202629
Completed
Not Applicable

Genotype and response to treatment for age related macular degeneration (ARMD): a multicentre, non-randomised, interventional, cohort study

eeds Teaching Hospitals NHS Trust (UK)0 sites350 target enrollmentMay 28, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
eeds Teaching Hospitals NHS Trust (UK)
Enrollment
350
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 28, 2010
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
eeds Teaching Hospitals NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged over 65 years, either sex
  • •2\. Affected with ARM
  • •3\. Currently under treatment with ranibizumab (Lucentis)
  • •4\. Patients with lesions of greatest linear diameter less than 5400 microns

Exclusion Criteria

  • •1\. Patients with poor general health
  • •2\. Patients with other eye pathology likely to affect response to treatment
  • •3\. Patients with lesions of greatest linear diameter greater than 5400 microns
  • •4\. Patients currently being treated with other anti\-VEGF agents (systemic or ocular)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Do genes predict response to treatment in age-related macular degeneration? - ARMD pharmacogenetics
EUCTR2008-007319-33-GBeeds Teaching Hospitals NHS Trust
Completed
Not Applicable
The evaluation of treatment effect for age-related macular degeneration by using aflibercept preferentially in Yamaguchi University.age-related macular degeneration
JPRN-UMIN000038335Department of Ophthalmology Yamaguchi University graduate school of medicine73
Completed
Not Applicable
Analysis of genotypes associated with the treatment effects of Lucentis for age-related macular degeneratioage-related macular degeneration
JPRN-UMIN000005584Kyoto University Graduate School of Medicine, Department of Ophthalmology and Visual Sciences600
Completed
Not Applicable
Genetic Markers of Response to Newer Therapies for Type 2 DiabetesE11Type 2 diabetes mellitus
DRKS00034478Faculty of Medicine, University of Ljubljana161
Completed
Not Applicable
GENetic and clinical Predictors Of treatment response in Depressio
ISRCTN31345163Medical Research Council (UK)887